疫苗接种-话题@MedSci

#疫苗接种#

377篇内容 | 5997人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1257925, encodeId=3429125e925ff, content=<a href='/topic/show?id=f538e0501e9' target=_blank style='color:#2F92EE;'>#疫苗接种#</a>, objectTitle=新冠疫苗接种35个热门核心问题详细解答（2020.1.24更新）, objectType=article, longId=206206, objectId=451320620620, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=451320620620, replyNumber=0, likeNumber=61, createdTime=2021-01-26, rootId=0, userName=lishiwen, userId=5c0050, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=451320620620, moduleTitle=新冠疫苗接种35个热门核心问题详细解答（2020.1.24更新）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=451320620620)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1257923, encodeId=edbd125e92362, content=<a href='/topic/show?id=f538e0501e9' target=_blank style='color:#2F92EE;'>#疫苗接种#</a>, objectTitle=NEJM：HPV疫苗接种与宫颈癌的患病风险, objectType=article, longId=206111, objectId=168f20611101, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=168f20611101, replyNumber=0, likeNumber=71, createdTime=2021-01-24, rootId=0, userName=lishiwen, userId=5c0050, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=168f20611101, moduleTitle=NEJM：HPV疫苗接种与宫颈癌的患病风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=168f20611101)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1257924, encodeId=b565125e92462, content=<a href='/topic/show?id=f538e0501e9' target=_blank style='color:#2F92EE;'>#疫苗接种#</a>, objectTitle=2020年HPV疫苗接种ACOG专家委员会意见【NO.809（取代2017年6月原704号）】, objectType=article, longId=206096, objectId=75c820609600, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=75c820609600, replyNumber=0, likeNumber=65, createdTime=2021-01-24, rootId=0, userName=lishiwen, userId=5c0050, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=75c820609600, moduleTitle=2020年HPV疫苗接种ACOG专家委员会意见【NO.809（取代2017年6月原704号）】, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=75c820609600)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1257922, encodeId=2cfa125e922c8, content=<a href='/topic/show?id=f538e0501e9' target=_blank style='color:#2F92EE;'>#疫苗接种#</a>, objectTitle=【预防接种日】人乳头瘤病毒（宫颈癌）疫苗接种的立场文件：来自欧洲妇科肿瘤学会- 欧洲阴道镜联盟（ESGO - EFC）, objectType=article, longId=206070, objectId=d7e92060e073, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d7e92060e073, replyNumber=0, likeNumber=62, createdTime=2021-01-24, rootId=0, userName=lishiwen, userId=5c0050, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d7e92060e073, moduleTitle=【预防接种日】人乳头瘤病毒（宫颈癌）疫苗接种的立场文件：来自欧洲妇科肿瘤学会- 欧洲阴道镜联盟（ESGO - EFC）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d7e92060e073)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1257921, encodeId=6c3d125e921cf, content=<a href='/topic/show?id=f538e0501e9' target=_blank style='color:#2F92EE;'>#疫苗接种#</a>, objectTitle=2021年1月20日全球新冠肺炎（COVID-19）疫情简报，确诊超9655万，春节前中国新冠疫苗接种人数有望达5000万人次, objectType=article, longId=205929, objectId=42bb205929be, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=42bb205929be, replyNumber=0, likeNumber=67, createdTime=2021-01-21, rootId=0, userName=lishiwen, userId=5c0050, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=42bb205929be, moduleTitle=2021年1月20日全球新冠肺炎（COVID-19）疫情简报，确诊超9655万，春节前中国新冠疫苗接种人数有望达5000万人次, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=42bb205929be)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1257920, encodeId=961b125e92078, content=<a href='/topic/show?id=f538e0501e9' target=_blank style='color:#2F92EE;'>#疫苗接种#</a>, objectTitle=新冠疫苗接种：中国接种人数超900万，数量居全球领先，以色列接种人口比例达20%，比例居全球领先, objectType=article, longId=205583, objectId=066d20558386, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=066d20558386, replyNumber=0, likeNumber=69, createdTime=2021-01-12, rootId=0, userName=lishiwen, userId=5c0050, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=066d20558386, moduleTitle=新冠疫苗接种：中国接种人数超900万，数量居全球领先，以色列接种人口比例达20%，比例居全球领先, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=066d20558386)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1257919, encodeId=fcb1125e919e4, content=<a href='/topic/show?id=f538e0501e9' target=_blank style='color:#2F92EE;'>#疫苗接种#</a>, objectTitle=是否会在石家庄等疫情比较严重的地区优先开展疫苗接种？国家卫健委这样回应, objectType=article, longId=205560, objectId=b5242055605e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b5242055605e, replyNumber=0, likeNumber=56, createdTime=2021-01-11, rootId=0, userName=lishiwen, userId=5c0050, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b5242055605e, moduleTitle=是否会在石家庄等疫情比较严重的地区优先开展疫苗接种？国家卫健委这样回应, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b5242055605e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1257918, encodeId=57b7125e91874, content=<a href='/topic/show?id=f538e0501e9' target=_blank style='color:#2F92EE;'>#疫苗接种#</a>, objectTitle=应接尽接、不收费用！国家卫健委公布这些新冠疫苗接种好消息, objectType=article, longId=205543, objectId=1726205543eb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1726205543eb, replyNumber=0, likeNumber=68, createdTime=2021-01-11, rootId=0, userName=lishiwen, userId=5c0050, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1726205543eb, moduleTitle=应接尽接、不收费用！国家卫健委公布这些新冠疫苗接种好消息, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1726205543eb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1257917, encodeId=a954125e917be, content=<a href='/topic/show?id=f538e0501e9' target=_blank style='color:#2F92EE;'>#疫苗接种#</a>, objectTitle=美疾控中心：辉瑞疫苗接种后已报告21起过敏反应, objectType=article, longId=205464, objectId=3208205464d7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3208205464d7, replyNumber=0, likeNumber=56, createdTime=2021-01-09, rootId=0, userName=lishiwen, userId=5c0050, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3208205464d7, moduleTitle=美疾控中心：辉瑞疫苗接种后已报告21起过敏反应, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3208205464d7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1257916, encodeId=3e3d125e9161e, content=<a href='/topic/show?id=f538e0501e9' target=_blank style='color:#2F92EE;'>#疫苗接种#</a>, objectTitle=2021年1月7日全球新冠肺炎（COVID-19）疫情简报，确诊超8755万，疫苗接种进度缓慢，未能阻止病毒加速传播，疫情控制要到2022年？, objectType=article, longId=205444, objectId=e33320544423, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e33320544423, replyNumber=0, likeNumber=58, createdTime=2021-01-08, rootId=0, userName=lishiwen, userId=5c0050, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e33320544423, moduleTitle=2021年1月7日全球新冠肺炎（COVID-19）疫情简报，确诊超8755万，疫苗接种进度缓慢，未能阻止病毒加速传播，疫情控制要到2022年？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e33320544423)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1257915, encodeId=7e23125e91524, content=<a href='/topic/show?id=f538e0501e9' target=_blank style='color:#2F92EE;'>#疫苗接种#</a>, objectTitle=2021年1月5日全球新冠肺炎（COVID-19）疫情简报，确诊超8599万，中美疫苗接种数量居前, objectType=article, longId=205344, objectId=760520534411, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=760520534411, replyNumber=0, likeNumber=74, createdTime=2021-01-06, rootId=0, userName=lishiwen, userId=5c0050, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=760520534411, moduleTitle=2021年1月5日全球新冠肺炎（COVID-19）疫情简报，确诊超8599万，中美疫苗接种数量居前, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=760520534411)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1257914, encodeId=61ce125e91409, content=<a href='/topic/show?id=f538e0501e9' target=_blank style='color:#2F92EE;'>#疫苗接种#</a>, objectTitle=2021年1月4日全球新冠肺炎（COVID-19）疫情简报，确诊超8545万，疫苗接种以色列全球领先，13%人口已接种, objectType=article, longId=205302, objectId=87e9205302ad, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=87e9205302ad, replyNumber=0, likeNumber=57, createdTime=2021-01-05, rootId=0, userName=lishiwen, userId=5c0050, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=87e9205302ad, moduleTitle=2021年1月4日全球新冠肺炎（COVID-19）疫情简报，确诊超8545万，疫苗接种以色列全球领先，13%人口已接种, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=87e9205302ad)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1257913, encodeId=c995125e913a7, content=<a href='/topic/show?id=f538e0501e9' target=_blank style='color:#2F92EE;'>#疫苗接种#</a>, objectTitle=探访北京新冠疫苗接种点：重点人群有序接种未来实现“应接尽接”, objectType=article, longId=205293, objectId=5c812052932b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5c812052932b, replyNumber=0, likeNumber=68, createdTime=2021-01-05, rootId=0, userName=lishiwen, userId=5c0050, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5c812052932b, moduleTitle=探访北京新冠疫苗接种点：重点人群有序接种未来实现“应接尽接”, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5c812052932b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1257912, encodeId=7ffa125e9129f, content=<a href='/topic/show?id=f538e0501e9' target=_blank style='color:#2F92EE;'>#疫苗接种#</a>, objectTitle=福奇：如提高新冠疫苗接种率，美国人或于明年初秋恢复正常生活, objectType=article, longId=205201, objectId=dc9e205201f1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dc9e205201f1, replyNumber=0, likeNumber=52, createdTime=2021-01-03, rootId=0, userName=lishiwen, userId=5c0050, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dc9e205201f1, moduleTitle=福奇：如提高新冠疫苗接种率，美国人或于明年初秋恢复正常生活, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=dc9e205201f1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1257911, encodeId=97e8125e911e9, content=<a href='/topic/show?id=f538e0501e9' target=_blank style='color:#2F92EE;'>#疫苗接种#</a>, objectTitle=2021年1月1日全球新冠肺炎（COVID-19）疫情简报，确诊超8377万，欧美疫苗接种缓慢, objectType=article, longId=205181, objectId=7cf5205181ef, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7cf5205181ef, replyNumber=0, likeNumber=88, createdTime=2021-01-03, rootId=0, userName=lishiwen, userId=5c0050, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7cf5205181ef, moduleTitle=2021年1月1日全球新冠肺炎（COVID-19）疫情简报，确诊超8377万，欧美疫苗接种缓慢, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7cf5205181ef)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1257910, encodeId=2bff125e91023, content=<a href='/topic/show?id=f538e0501e9' target=_blank style='color:#2F92EE;'>#疫苗接种#</a>, objectTitle=新冠疫苗接种30个热门核心问题详细解答（2020.12.31更新）, objectType=article, longId=205064, objectId=379620506470, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=379620506470, replyNumber=0, likeNumber=42, createdTime=2021-01-01, rootId=0, userName=lishiwen, userId=5c0050, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=379620506470, moduleTitle=新冠疫苗接种30个热门核心问题详细解答（2020.12.31更新）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=379620506470)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1257909, encodeId=7c3a125e90914, content=<a href='/topic/show?id=f538e0501e9' target=_blank style='color:#2F92EE;'>#疫苗接种#</a>, objectTitle=全国多地启动新冠疫苗接种，25个热门问题详细解答, objectType=article, longId=204922, objectId=ee1520492247, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ee1520492247, replyNumber=0, likeNumber=50, createdTime=2020-12-29, rootId=0, userName=lishiwen, userId=5c0050, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ee1520492247, moduleTitle=全国多地启动新冠疫苗接种，25个热门问题详细解答, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ee1520492247)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1257908, encodeId=940f125e9083a, content=<a href='/topic/show?id=f538e0501e9' target=_blank style='color:#2F92EE;'>#疫苗接种#</a>, objectTitle=上海已启动新冠疫苗接种，21个热门问题详细解答, objectType=article, longId=204915, objectId=e5b92049157f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e5b92049157f, replyNumber=0, likeNumber=19, createdTime=2020-12-28, rootId=0, userName=lishiwen, userId=5c0050, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e5b92049157f, moduleTitle=上海已启动新冠疫苗接种，21个热门问题详细解答, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e5b92049157f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1257907, encodeId=411f125e9073b, content=<a href='/topic/show?id=f538e0501e9' target=_blank style='color:#2F92EE;'>#疫苗接种#</a>, objectTitle=美国CDC通过辉瑞疫苗接种决议，全国开始疫苗分发接种, objectType=article, longId=204519, objectId=9cfa204519f8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9cfa204519f8, replyNumber=0, likeNumber=15, createdTime=2020-12-17, rootId=0, userName=lishiwen, userId=5c0050, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9cfa204519f8, moduleTitle=美国CDC通过辉瑞疫苗接种决议，全国开始疫苗分发接种, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9cfa204519f8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1257906, encodeId=e9af125e906c3, content=<a href='/topic/show?id=f538e0501e9' target=_blank style='color:#2F92EE;'>#疫苗接种#</a>, objectTitle=2020年12月7日全球新冠肺炎（COVID-19）疫情简报，确诊超6734万，多国将启动大规模新冠疫苗接种, objectType=article, longId=204255, objectId=70d72042552e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=70d72042552e, replyNumber=0, likeNumber=60, createdTime=2020-12-08, rootId=0, userName=lishiwen, userId=5c0050, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=70d72042552e, moduleTitle=2020年12月7日全球新冠肺炎（COVID-19）疫情简报，确诊超6734万，多国将启动大规模新冠疫苗接种, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=70d72042552e)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

疫苗接种

2020-05-29

lishiwen (审核中...)

前往app查看评论内容

#疫苗接种#

新冠疫苗接种35个热门核心问题详细解答（2020.1.24更新）

2021-01-26

lishiwen (审核中...)

前往app查看评论内容

#疫苗接种#

NEJM：HPV疫苗接种与宫颈癌的患病风险

2021-01-24

lishiwen (审核中...)

前往app查看评论内容

#疫苗接种#

2020年HPV疫苗接种ACOG专家委员会意见【NO.809（取代2017年6月原704号）】

2021-01-24

lishiwen (审核中...)

前往app查看评论内容

#疫苗接种#

【预防接种日】人乳头瘤病毒（宫颈癌）疫苗接种的立场文件：来自欧洲妇科肿瘤学会- 欧洲阴道镜联盟（ESGO - EFC）

2021-01-24

lishiwen (审核中...)

前往app查看评论内容

#疫苗接种#

2021年1月20日全球新冠肺炎（COVID-19）疫情简报，确诊超9655万，春节前中国新冠疫苗接种人数有望达5000万人次

2021-01-21

lishiwen (审核中...)

前往app查看评论内容

#疫苗接种#

新冠疫苗接种：中国接种人数超900万，数量居全球领先，以色列接种人口比例达20%，比例居全球领先

2021-01-12

lishiwen (审核中...)

前往app查看评论内容

#疫苗接种#

是否会在石家庄等疫情比较严重的地区优先开展疫苗接种？国家卫健委这样回应

2021-01-11

lishiwen (审核中...)

前往app查看评论内容

#疫苗接种#

应接尽接、不收费用！国家卫健委公布这些新冠疫苗接种好消息

2021-01-11

lishiwen (审核中...)

前往app查看评论内容

#疫苗接种#

美疾控中心：辉瑞疫苗接种后已报告21起过敏反应

2021-01-09

lishiwen (审核中...)

前往app查看评论内容

#疫苗接种#

2021年1月7日全球新冠肺炎（COVID-19）疫情简报，确诊超8755万，疫苗接种进度缓慢，未能阻止病毒加速传播，疫情控制要到2022年？

2021-01-08

lishiwen (审核中...)

前往app查看评论内容

#疫苗接种#

2021年1月5日全球新冠肺炎（COVID-19）疫情简报，确诊超8599万，中美疫苗接种数量居前

2021-01-06

lishiwen (审核中...)

前往app查看评论内容

#疫苗接种#

2021年1月4日全球新冠肺炎（COVID-19）疫情简报，确诊超8545万，疫苗接种以色列全球领先，13%人口已接种

2021-01-05

lishiwen (审核中...)

前往app查看评论内容

#疫苗接种#

探访北京新冠疫苗接种点：重点人群有序接种未来实现“应接尽接”

2021-01-05

lishiwen (审核中...)

前往app查看评论内容

#疫苗接种#

福奇：如提高新冠疫苗接种率，美国人或于明年初秋恢复正常生活

2021-01-03

lishiwen (审核中...)

前往app查看评论内容

#疫苗接种#

2021年1月1日全球新冠肺炎（COVID-19）疫情简报，确诊超8377万，欧美疫苗接种缓慢

2021-01-03

lishiwen (审核中...)

前往app查看评论内容

#疫苗接种#

新冠疫苗接种30个热门核心问题详细解答（2020.12.31更新）

2021-01-01

lishiwen (审核中...)

前往app查看评论内容

#疫苗接种#

全国多地启动新冠疫苗接种，25个热门问题详细解答

2020-12-29

lishiwen (审核中...)

前往app查看评论内容

#疫苗接种#

上海已启动新冠疫苗接种，21个热门问题详细解答

2020-12-28

lishiwen (审核中...)

前往app查看评论内容

#疫苗接种#

美国CDC通过辉瑞疫苗接种决议，全国开始疫苗分发接种

2020-12-17

lishiwen (审核中...)

前往app查看评论内容

#疫苗接种#

2020年12月7日全球新冠肺炎（COVID-19）疫情简报，确诊超6734万，多国将启动大规模新冠疫苗接种

2020-12-08

科室
- - 订阅+
  - 更多科室
工具
服务